Somatostatin-25 is a endogenous neuropeptide hormone that shows inhibitory activity against secretion of growth hormone.
CAT No: R1684
CAS No:76461-17-1
Synonyms/Alias:Somatostatin-25;Somatostatin 25;76461-17-1;DA-67694;
Somatostatin-25 is a synthetic peptide analog of the naturally occurring neuropeptide somatostatin, characterized by its extended amino acid sequence and enhanced biological stability. As a regulatory peptide, it plays a pivotal role in modulating endocrine and neuroendocrine signaling pathways, influencing the release of several critical hormones and neurotransmitters. Its unique structural features and receptor-binding properties have made it a valuable tool in the study of peptide-receptor interactions, intracellular signaling cascades, and the broader field of neuropeptide research. Researchers utilize Somatostatin-25 to dissect complex regulatory mechanisms underlying hormone secretion, neuronal communication, and physiological homeostasis.
Receptor binding studies: Somatostatin-25 is frequently employed in receptor binding assays to elucidate the specificity and affinity of various somatostatin receptor subtypes. Its extended peptide sequence allows for the investigation of binding dynamics and receptor-ligand interactions that differ from those observed with shorter somatostatin analogs. This application is particularly relevant for characterizing receptor pharmacology, mapping receptor distribution in tissues, and supporting the development of novel receptor-targeted compounds.
Signal transduction research: The peptide serves as a powerful probe for examining the downstream effects of somatostatin receptor activation on intracellular signaling pathways. By modulating key effectors such as cyclic AMP, calcium flux, and protein kinase activity, Somatostatin-25 enables researchers to delineate the molecular mechanisms by which somatostatin influences cellular physiology. These studies are essential for understanding the regulatory networks that control hormone release, neurotransmission, and cellular proliferation.
Endocrine regulation assays: In vitro and ex vivo experiments often utilize Somatostatin-25 to assess its impact on the secretion of hormones such as growth hormone, insulin, glucagon, and gastrointestinal peptides. Its ability to inhibit or modulate hormone release provides a functional readout for evaluating endocrine feedback loops and the physiological consequences of altered somatostatin signaling. This application is critical for advancing knowledge of metabolic regulation and the coordination of hormonal responses.
Peptide stability and degradation studies: Due to its extended structure, Somatostatin-25 offers a unique model for investigating peptide degradation kinetics and metabolic stability in biological systems. Researchers can use it to assess the susceptibility of peptide therapeutics to enzymatic cleavage, identify metabolic breakdown products, and develop strategies for enhancing peptide bioavailability. Such studies inform the rational design of more stable peptide analogs for research applications.
Peptide synthesis and analytical method development: As a structurally complex peptide, Somatostatin-25 is valuable for validating and optimizing synthetic methodologies in peptide chemistry. Its use in chromatographic, spectrometric, and mass spectrometric analyses assists in refining purification protocols and analytical detection techniques. These efforts support quality control, structural characterization, and the advancement of peptide-based research tools across a range of scientific disciplines.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.